|
Volume 272, Number 16,
Issue of April 18, 1997
pp. 10491-10497
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Post-Golgi Vesicles Cotransport Docosahexaenoyl-Phospholipids and
Rhodopsin during Frog Photoreceptor Membrane Biogenesis*
(Received for publication, September 19, 1996, and in revised form, December 30, 1996)
Elena B. Rodriguez
de Turco
,
Dusanka
Deretic
§,
Nicolas G.
Bazan
¶ and
David S.
Papermaster
From the LSU Neuroscience Center and Department of
Ophthalmology, Louisiana State University Medical Center, School of
Medicine, New Orleans, Louisiana 70112, the § University
of Michigan, Departments of Ophthalmology and Anatomy and Cell Biology,
Ann Arbor, Michigan 48105, and Univeristy of Texas, Health
Science Center, Department of Pathology,
San Antonio, Texas 78284-7750
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
Post-Golgi vesicles budding from the trans-Golgi
network (TGN) are involved in the vectorial transport and delivery of
rhodopsin to photoreceptor rod outer segments (ROS). We report here
that newly synthesized docosahexaenoyl (DHA) phospholipids are
sequestered and cotransported by rhodopsin-bearing post-Golgi vesicles
to ROS. Frog retinas were pulse-labeled with
[35S]methionine/cysteine and [3H]DHA
prior to ROS isolation and subcellular fractionation. After a 1-h
pulse, relatively uniform [3H]DHA-lipid labeling
(DPM/µg protein) was observed in all fractions enriched in post-Golgi
vesicles, TGN, Golgi, and endoplasmic reticulum (ER) membranes. During
the subsequent 2-h chase translocation of free [3H]DHA
from ROS to the photoreceptor inner segment contributed to an
additional overall increase in labeling of lipids. The specific activity (dpm/nmol DHA) in ER-enriched fraction was similar or higher
than in other subcellular fractions after both the pulse and the chase,
indicating that the bulk of [3H]DHA-lipids was
synthesized in the ER. After the chase a 2-fold increase in labeling of
lipids in the ER and Golgi and a 2.6-fold in lighter TGN-enriched
fractions was observed. The highest labeling was in the post-Golgi
vesicle fraction (4-fold increase), with [3H]DHA-phosphatidylcholine and
[3H]DHA-phosphatidylethanolamine showing the greatest
increase. At the same time, newly synthesized
[35S]rhodopsin shifted from the ER and Golgi toward TGN
and post-Golgi fractions. Therefore, sequestration and association of
[35S]rhodopsin and [3H]DHA-lipids in a TGN
membrane domain occurs prior to their exit and subsequent vectorial
cotransport on post-Golgi vesicles to ROS. Labeling of ROS lipids was
very low, with phosphatidylinositol and diacylglycerols displaying the
highest labeling. This indicates that other mechanisms by-passing
Golgi, i.e. facilitated by lipid carrier proteins, may also
contribute to molecular replacement of disc membrane DHA-phospholipids,
particularly phosphatidylinositol.
INTRODUCTION
Vertebrate photoreceptors are polarized and compartmentalized
cells, with a photosensitive outer segment and a synaptic terminal domain at opposite ends of the cell. These domains are attached through
a connecting cilium and a short axon, respectively, to a central
region, the inner segment. The inner segment is the site where lipid
and protein synthesis, polarized sorting of molecules, and initiation
of membrane biogenesis for both the outer segment and synaptic
terminals take place. Disc membranes in rod outer segments
(ROS)1 display a unique lipid-protein
composition. The visual pigment rhodopsin, which accounts for more than
85% of disc membrane proteins (1), is embedded within a highly fluid
lipid bilayer comprised of phospholipids (PLs) highly enriched in
docosahexaenoic acid (DHA, 22:6n-3) (2-6).
Amphibian photoreceptor cells are a useful experimental model to study
protein and lipid trafficking in a polarized cell. Photoreceptors
actively synthesize proteins (mainly rhodopsin) and DHA-PLs to support
the dynamic daily renewal of 50-80 large disc membranes in each rod
cell that results in the addition of membrane at 3
µm2/min (7, 8). ROS lack the capacity for de
novo synthesis of PLs (4, 9). Therefore, they depend entirely on
an external supply of PLs from the inner segment where they are
synthesized mainly in the rough endoplasmic reticulum (ER) (10). How
these highly unsaturated lipids become components of ROS membranes and at which stage of membrane biosynthesis and disc morphogenesis they
become associated with rhodopsin is not yet clear.
Newly synthesized rhodopsin is vectorially transported from its site of
synthesis in the rough ER to ROS by vesicles that bud from the
trans-Golgi network (TGN), cluster beneath the connecting cilium, and
fuse with the inner segment plasma membrane within the periciliary
ridge complex (11, 12). A very low buoyant density ( = 1.09 g/ml)
post-Golgi vesicular subcellular fraction carrying newly synthesized
rhodopsin has been isolated and characterized from frog retinal
photoreceptor cells (12-15). Whereas rhodopsin and the bulk of DHA-PLs
are synthesized in the rough ER and both can follow a vesicle-mediated
traffic through the biosynthetic pathway, other mechanisms can
contribute to trafficking and selective delivery of PLs to
intracellular organelles (16-18). For example, the rapid monomer
transport of PLs is facilitated by transfer proteins (TP) through the
cytosol (19). A transfer protein that with high affinity transfers PC
to ROS membranes has also been described (20), and immunohistochemical
analysis of chicken retinas at hatching revealed the presence of
phosphatidylinositol (PI)-TP in retinal cells including the inner
segment of photoreceptors (21).
Phospholipid renewal of ROS membranes involves both membrane
replacement (as new disc membranes are assembled at the base of the
ROS) and molecular replacement (i.e. PL transfer protein mediated and remodeling of disc PLs by turnover) (22, 23). Using
various radiolabeled lipid precursors under experimental conditions
that inhibit protein synthesis or vesicle-mediated transport, lipids
can be transported to ROS by independent pathways by-passing the Golgi
(24-28). However sorting of DHA-PLs, vectorial transport to ROS, and
the contribution of alternative pathways to their trafficking has not
been experimentally addressed. This question is especially intriguing
because biochemical and autoradiographic studies of
[3H]DHA trafficking in frog photoreceptors after in
vitro (29, 30) and in vivo (31, 32) labeling have
disclosed that newly synthesized [3H]DHA-PLs display a
polarized delivery to ROS, where they are incorporated at the base as
new discs are formed, in a pattern paralleling incorporation of
radiolabeled amino acids into disk membrane proteins.
The aim of the current study was to investigate if newly synthesized
DHA-lipids could be, at least in part, segregated and cotransported
with rhodopsin in vesicles budding from the TGN and then enter the ROS
as new membranes are formed (membrane replacement). To address this
question, we pulse-labeled frog retinas for 1 h in the presence of
[3H]DHA and [35S]methionine/cysteine,
followed by a 2-h chase in a cold buffer prior to subcellular
fractionation (12, 33). [3H]DHA was chosen because this
precursor is actively esterified into PLs in the inner segment of
photoreceptor (34-38) prior to their vectorial transport to the
ellipsoid region at the base of ROS and also to synaptic terminals (29,
30). Our results reveal that newly synthesized
[3H]DHA-PLs, especially the main components of disc
membranes (i.e. DHA-phosphatidylcholine (PC) and
DHA-phosphatidylethanolamine (PE)), are segregated and loaded together
with newly synthesized [35S]rhodopsin in post-Golgi
vesicles. Some lipids, i.e. [3H]DHA-PI and
[3H]DHA-diacylglycerols (DAG), are very rapidly
synthesized and delivered to ROS probably by alternative pathways that
by-pass the Golgi and may be facilitated by carrier proteins.
EXPERIMENTAL PROCEDURES
Frogs, Rana berlandieri (100-250 g), were purchased
from Rana Co. (Brownsville, TX), maintained in a 12-h light/12-h dark cycle, and fed crickets for a week prior to the experiment. [4, 5-3H]DHA (specific activity 17 Ci/mmol) and
[35S]Express protein labeling mixture (1,000 Ci/mmol)
were from DuPont NEN. High performance thin layer chromatographic
plates (10 × 10 cm, 150 µm thickness) were from Analtech
(Newark, DE). Lipids and fatty acid methyl ester standards and protease
inhibitors were from Sigma. High performance liquid chromatography
grade solvents were from EM Science (Gibbstown, NJ). All other reagents used were of the highest purity available.
In Vitro Labeling of Retinal Lipids and Proteins with
[3H]DHA and
[35S]Methionine/Cysteine
Retinas recovered from
frog eyecups 2 h before the time of light offset were dissected
and subsequently incubated under dim red light. Two sets of 21 retinas
were incubated in 30 ml of an oxygenated medium as described (14, 35)
at 22 °C in the presence of [3H]DHA (5.7 µCi/retina,
final DHA concentration 0.24 µM), and
[35S]Express protein labeling mixture (25 µCi/retina)
for 1 h. One set of retinas was further incubated for 2 h in
cold buffer containing unlabeled amino acids (pulse-chase samples)
prior to subcellular fractionation. Since the in vitro
retinal metabolism of [3H]DHA is altered at
µM DHA concentrations (29, 30, 39), cold DHA was not
added during the chase. Therefore, this chase period will hereafter be
identified as "chase" to reflect this condition.
Rod Outer Segments Isolation and Retinal Subcellular
Fractionation
All the procedures followed for the isolation of
ROS and subcellular fractionation have been described in detail
elsewhere (12, 33). Briefly, following the pulse and pulse-chase
labeling, retinas were sheared through a 14-gauge needle, and ROS were
separated by flotation on 34% sucrose. Retinal pellets were
rehomogenized in 0.25 M sucrose in 10 mM Tris
acetate, pH 7.4, containing 1 mM MgCl2 and
centrifuged for 4 min at 4,000 rpm (1250 gav,
JA20 rotor, Beckman Instruments, Inc., Palo Alto, CA). The postnuclear supernatant (3 ml) recovered after this centrifugation is enriched in
photoreceptor biosynthetic membranes and organelles involved in
rhodopsin transport (12, 33). To isolate post-Golgi vesicles from TGN,
Golgi, and ER membranes, the postnuclear supernatant was overlaid on a
10-ml linear 20-39% (w/w) sucrose gradient in 10 mM Tris
acetate buffer, pH 7.4, containing protease inhibitors and 1 mM MgCl2, above a 0.5-ml cushion of 49% (w/w)
sucrose in the same buffer. Gradients were centrifuged for 13 h at
4 °C in a SW40 rotor (Beckman) at 28,000 rpm (100,000 gav). Fourteen fractions (0.9 ml each) were
reproducibly collected from the top of the gradient. A Buchler Auto
Densi-Flow fractionator was used to prepare the gradient and to collect
the fractions. The subcellular fractions were diluted 4-fold with 10 mM Tris-HCl and pelleted at 50,000 rpm (240,000 gav) for 40 min in a SW50 rotor. The pellets
were resuspended in 210 µl of Tris acetate, pH 7.4, and divided into two aliquots, one-third for protein analysis and two-thirds for lipid
analysis.
Protein Analysis
SDS-polyacrylamide gel electrophoresis was
performed as described previously (12). 35S-Labeled
rhodopsin was determined in subcellular fractions by exposure of dried
SDS gels to storage phosphor screens, and the intensity of luminescence
associated with the rhodopsin band was measured and analyzed by a
PhosphorImager densitometer (Molecular Dynamics). Total proteins were
quantified according to Fanger (40), using bovine serum albumin as a
standard.
Lipid Extraction and Analysis
Lipids were extracted from
the fractions by adding 3 ml of chloroform:methanol (2:1, v/v)
following the Folch procedure (41). Individual phospholipids and
neutral lipids were isolated in the same TLC plate following a
two-dimensional, three-step TLC procedure (6) as follows: an aliquot of
the labeled lipid extract containing phospholipid and neutral lipid
standards as a carriers was applied on the lower right corner (1.5 cm
from each border) of 10 × 10 cm high performance thin layer
chromatography plates previously sprayed with 3% magnesium acetate and
activated for at least 1 h at 100 °C. The plate was developed
in the first dimension twice using the Rouser I chromatographic system
(chloroform/methanol/ammonia, 65:25:5, v/v) until the solvent front
reached 2 cm from the top of the plate. After drying with cold air, the
plate was turned to the right 90°, and neutral lipid standards
(cholesterol ester, triacylglycerol, diacylglycerol, and
monoacylglycerol) were spotted 1.5 cm from the bottom and 0.5 cm from
the right border. Plates were then developed in hexane/ether (60:40,
v/v) to isolate individual neutral lipids that had accumulated at the
front of the first chromatographic system. The silica gel was cut with
a vertical line to isolate neutral lipid (right) from phospholipid
(left) areas of the plate (approximately 3 cm from the right border), and the silica was scraped off from the bottom right corner prior to
running the plates in the Rouser II system (chloroform/acetone/ methanol/acetic acid, 30:40:10:10:5, v/v). This third chromatographic step, run in the same direction as the second step, allows the isolation of individual phospholipid classes and free fatty acids that
run with the solvent front above PE. Lipid spots were visualized by
iodine staining, and the radioactivity was determined in a Beckman
scintillation counter.
Aliquots of lipid extracts were taken for gas-liquid chromatography
analysis of endogenous fatty acid content and composition. Fatty acid
methyl esters were prepared in glass tubes by transmethylation with 2 ml of toluene/methanol/sulfuric acid (100:100:4, v/v) for 4 h at
65 °C, after flushing the tubes with nitrogen and capping with a
Teflon-lined cap. The tubes were cooled at room temperature, and 1 ml
of water, 3 ml of hexane, and a mixture of two internal standards (17:0
and 21:0 methyl esters) were added. Fatty acid methyl esters
resuspended in hexane were separated onto a SP-2330 column (30 m, 0.25 mm inner diameter, 0.2-µm film thickness, Suppelco, Bellefonte, PA)
by using helium as a carrier gas, in a Varian Vista 401 gas
chromatograph (Palo Alto, CA). The injector and detector temperatures
were 220 and 250 °C, respectively, and the column temperature was
programmed from 70 to 230 °C (42). The peaks were detected by flame
ionization, identified by comparison with the retention times of
authentic fatty acid methyl esters standard, and quantified using the
internal standards.
Statistical Analysis
Values for [3H]DHA lipid
labeling and [35S]rhodopsin are presented as a mean ± S.E. for n = four individual experiments. Data were
compared using Student's t test for pair samples. A
p value of < 0.05 was considered statistically
significant.
RESULTS
Post-Golgi Vesicles Are Enriched with Newly Synthesized
[35S]Rhodopsin and [3H]DHA-Lipids
To
determine whether newly synthesized [3H]DHA-PLs and
[35S]rhodopsin are transported together in the same
population of post-Golgi vesicles recovered in fraction 5 of the
sucrose gradient, retinas were pulse-labeled for 1 h in the
presence of both precursors and further incubated for 2 h (chase)
in cold buffer prior to subcellular fractionation. This experimental
protocol gives sufficient labeling of newly synthesized rhodopsin
within 1-h pulse and a maximum labeling of the vesicles (fraction 5)
during the following 2-h chase (12, 43). While the total
[35S]rhodopsin labeling recovered from the combined 14 fractions was similar for pulse and chase samples (data not shown),
total esterified [3H]DHA was increased by 2.6 ± 0.2-fold: from 1.2 × 106 dpm/21 retinas after a 1-h
pulse to 3.2 × 106 dpm/21 retinas after a 2-h chase.
After 1 h of pulse labeling, 58% of total
[35S]rhodopsin was recovered in TGN and Golgi (fractions
7-11) (Fig. 1) as expected (12). After a 2-h
"chase," a shift toward post-Golgi fractions 4-6 was observed,
with fraction 5 displaying the greatest increase (ratio chase/pulse:
2.4 ± 0.5). The profile of total esterified [3H]DHA
among subcellular fractions was similar to that of
[35S]rhodopsin (Fig. 1), with the highest percent values
observed in those fractions that also accumulated the largest
proportion of membranes (Fig. 2D). Remarkably
after the 2-h chase only post-Golgi fraction 5 displayed significantly
higher [3H]DHA percent labeling (ratio chase/pulse,
1.7 ± 0.2) at the time when newly synthesized
[35S]rhodopsin accumulated in this fraction.
Simultaneously, percent labeling in fractions 12 and 13 was lower than
during the pulse.
Fig. 1.
Newly synthesized
[3H]DHA-lipids and [35S]rhodopsin exit the
TGN in very low buoyant density vesicles recovered in the sucrose density gradient fraction 5. Twenty-one frog retinas were incubated for 1 h with [3H]DHA and
[35S]methionine/cysteine followed by a 2-h chase in cold
buffer containing unlabeled amino acids. Aliquots were taken from each
fraction recovered after pulse and chase labeling for lipid and protein analysis. Lipids were extracted and isolated by TLC. Esterified [3H]DHA was estimated after subtraction of the free
[3H]DHA from total labeling. Proteins were separated by
SDS-gel electrophoresis, and the radioactivity incorporated into
[35S]rhodopsin was determined by a PhosphorImager
densitometer. Mean values ± S.E. from n = four
separate experiments are shown and represent the percent distribution
of total labeling recovered from the 14 fractions of the gradient. S.E.
are shown when the range is larger than the symbol. Asterisk
denotes values that are significantly different from pulse labeling
(p < 0.05, Student's t test).
C, cytosol; PG, post-Golgi vesicles;
TGN, trans-Golgi network; G, Golgi;
ER, endoplasmic reticulum.
[View Larger Version of this Image (32K GIF file)]
Fig. 2.
[3H]DHA-lipids attain a
relatively uniform labeling in all fractions after a 1-h pulse.
After a 2-h chase newly synthesized lipids accumulate in fractions
containing post-Golgi vesicles recovered in fraction 5. Lipid labeling
was normalized to protein content of individual subcellular fractions
and shown as a mean value in dpm/µg protein ± S.E.
(n = 4). A, free [3H]DHA was
isolated from phospholipids and neutral lipids by a two-dimensional,
three-step TLC as detailed under "Experimental Procedures."
B, total esterified [3H]DHA is the sum of
[3H]DHA found esterified into phospholipids and neutral
lipids. C, the ratio of chase/pulse labeling of total
[3H]DHA esterified into lipids. D, protein
content of individual subcellular fractions. Mean values ± S.E.
from n = 8 determinations including all the pulse and
chase samples are shown. Other details as in Fig. 1 legend.
[View Larger Version of this Image (23K GIF file)]
Labeling recovered from individual subcellular fractions based upon
protein content is shown in Fig. 2 and reveals four features. First,
after a 1-h pulse, all fractions displayed similar labeling of
esterified [3H]DHA (Fig. 2B). Second, after
the subsequent 2-h "chase," labeling of DHA-lipids increased at
least 2-fold in the heavy fractions that correspond to the density of
ER (13-14), Golgi (11-12), and TGN (10), by 2.6-fold in lighter TGN
fractions 7-9, and peaking at 4-fold higher labeling in post-Golgi
vesicles recovered in fraction 5 as compared with pulse-labeled values
(Fig. 2, B-C). Third, no significant difference
between pulse and chase labeling was observed in the free
[3H]DHA pool, indicating an equilibrium between the
arrival of the precursor to these membrane compartments and its
esterification into lipids either by de novo synthesis
and/or turnover (Fig. 2A). The peak of labeling observed in
fraction 8 may be the result of free [3H]DHA contributed
by a small proportion of heavily labeled ROS cosedimenting between
fractions 7 and 9 at a buoyant density of 1.13 g/ml (12). Fourth, most
of the label recovered from ROS after pulse and chase labeling was
found as free DHA (92 ± 1 and 76 ± 1%, respectively) (Fig.
2A), whereas ROS lipids labeling was the lowest among all
subcellular fractions analyzed (Fig. 2B). A 2.5-fold
increase in ROS [3H]DHA-lipids labeling after the
"chase" (from 138 ± 25 to 350 ± 40 dpm/µg protein)
accounted for by the concomitant loss of only 15% of free
[3H]DHA (from 2600 to 1160 dpm/µg protein).
The specific activity of total [3H]DHA-lipids (dpm/nmol
of endogenous DHA content) showed that fraction 14 (ER) displayed, after both the pulse (2790 ± 245 dpm/nmol DHA) and the
"chase" (5060 ± 840 dpm/nmol DHA) labeling, similar or higher
values than other fractions. After the pulse labeling, the specific
activity of fraction 5 (1990 ± 115 dpm/nmol DHA) was
significantly lower than that of fraction 14 (p < 0.05). After the chase, the specific activity of fraction 5 increased
3-fold (6580 ± 550 dpm/nmol DHA) but was not significantly
different from the specific activity of fraction 14 (p > 0.19).
Phosphatidylcholine, Phosphatidylethanolamine, and
Phosphatidylinositol Are Highly Labeled in All Subcellular Fractions;
[3H]DHA-PC and [3H]DHA-PE Preferentially
Shift toward Post-Golgi Vesicles (Fraction 5) after the Chase
The
two most abundant PLs in retinal membranes, PC and PE, reveal a similar
labeling profile after a 2-h "chase" (Fig. 3). [3H]DHA-PC and [3H]DHA-PE gradually
increased from fractions enriched in ER to heavy fractions of the TGN,
with a sharp peak in post-Golgi fraction 5 reaching a 5.2- and 4.6-fold
increase, respectively, above pulse labeling. The profile of
[3H]DHA-PI was very similar to that of
[3H]diacylglycerol (DAG), and their labeling was
significantly increased only in TGN fractions 7-9, with the highest
increase in post-Golgi fraction 5 (3.9- and 2.5-fold, respectively). PS
was the only phospholipid that did not show a peak of labeling in
fraction 5 but displayed 3-fold increase between fractions 5 and 7. Phosphatidic acid (PA) labeling gradually increased from ER fractions
to post-Golgi fraction 5 with no significant differences from the 1-h
pulse labeling.
Fig. 3.
[3H]DHA-PC and
[3H]DHA-PE are the phospholipids that display the highest
increase of labeling in rhodopsin bearing post-Golgi vesicles after the
chase. Total dpm recovered in individual lipids per µg protein
are shown. Insets, labeling of ROS lipids (dpm per µg of
protein) after pulse (open bars) and chase (closed bars). Other details as in Fig. 1 legend.
[View Larger Version of this Image (53K GIF file)]
[3H]DHA-PL labeling in ROS was very low (Fig. 3,
insets) with a different pattern of distribution than all
other subcellular fractions (Fig. 4). Although the small
amount of ROS that is recovered in the gradient between fraction 7 and
9 may contribute to their highly free [3H]DHA labeling
(Fig. 2), it cannot contribute to but rather results in an
underestimation of lipid labeling in these fractions that arise from
inner segment membranes. [3H]DHA-PI displayed, by far,
the highest labeling in ROS, with a 7.9-fold increase after a 2-h
"chase," followed by DAG (4.8-fold), PC, and PS (3-fold each). No
differences were observed between a 1-h pulse and 2-h "chase"
labeling in [3H]DHA-PE and [3H]DHA-PA (Fig.
3, insets). This short-term incubation may reflect the
labeling of disc membrane lipids by molecular replacement including
(a) [3H]DHA incorporation by turnover,
(b) the fast transport from the inner segment of a portion
of newly synthesized [3H]DHA-lipids (i.e.
[3H]DHA-PI), and/or (c) further metabolism of
newly incorporated [3H]DHA-PLs into ROS such as
N-methylation of [3H]DHA-PE to
[3H]DHA-PC (4, 44).
Fig. 4.
[3H]DHA-PI,
[3H]DHA-PC, and [3H]DHA-PE display the
highest percent labeling in all retinal subcellular fractions except
for ROS which show the highest labeling in [3H]DHA-PI and
[3H]DHA-DAG. Values represent percent labeling of
individual lipids with respect to total [3H]DHA recovered
esterified into lipids. Other details as Fig. 1 legend.
[View Larger Version of this Image (40K GIF file)]
The percent distribution of esterified [3H]DHA displayed
high values for PI, PC, and PE in all fractions except for ROS (Fig. 4). In fraction 5 they reached a similar value (28%), although in
other fractions, PI labeling alone prevailed. The highest percent labeling of PI was observed in fraction 1 (48%) and to a lesser extent
in fraction 2 (34%), probably associated with cytosolic proteins
recovered at the top of the gradient that may sediment after the 40,000 centrifugation (12). The ratio PI to PC labeling was higher in TGN
fractions as compared with post-Golgi fractions 4-6, showing the
highest value in fraction 8 of the TGN after both pulse and chase
labeling (Fig. 5).
Fig. 5.
Lipids from TGN fraction 8 display the
highest [3H]DHA-PI/[3H]DHA-PC ratio.
Upper panel, values represent percent labeling of PI and PC
with respect to total esterified [3H]DHA recovered in
lipids from individual subcellular fractions. Lower panel,
ratios of percent [3H]DHA-PI/[3H]DHA-PC
after pulse and chase labeling. Other details as Fig. 1 legend.
[View Larger Version of this Image (24K GIF file)]
The Content of Endogenous Fatty Acyl Chains of Lipids from
Post-Golgi Vesicular Fractions
Total fatty acyl group content,
reflecting mainly membrane phospholipids, increased gradually from the
heaviest, ER-enriched fractions (2 nmol/µg protein) to the post-Golgi
light vesicular fractions 4-5 (4 nmol/µg protein) (Fig.
6). The endogenous DHA content was very similar for all
fractions (approximately 20% of total acyl groups) except for TGN
fractions 7-9 where ROS, not completely removed prior to subcellular
fractionation, cosedimented. In ROS, DHA accounted for 50% of total
acyl groups. The lower % DHA content in fraction 5 as compared with
ROS suggests that either the lipids from the vesicles bearing rhodopsin
are less enriched in DHA-lipid and/or that lipids contributed by other vesicles with a lower degree of unsaturation are recovered in this
fraction. The latter possibility is unlikely since immunoisolation of
rhodopsin-bearing post-Golgi vesicles with anti-rhodopsin antibody indicated that they constitute >85% of the vesicles sedimenting in
fraction 5 of the gradient (12). The net amount of DHA per protein in
ROS (1.93 nmol/µg) was twice that of lipids from fraction 5 vesicles
(0.85 nmol/µg protein). Although rhodopsin is the most abundant
protein recovered in fraction 5, its contribution to the total proteins
in the fraction is less than 50%, whereas rhodopsin accounts for
85-90% of total ROS proteins (12). Therefore, the net amount of
DHA-PLs with respect to rhodopsin protein in these post-Golgi vesicles
may reach values similar to that of ROS.
Fig. 6.
Lipids from post-Golgi vesicle fraction 5 display a similar content of lipid-acyl groups but a lower content of
DHA as compared with ROS membranes. An aliquot of lipid extracts was derivatized to fatty acid methyl esters, and their content and acyl
group composition was analyzed by GLC as detailed under "Experimental
Procedures." The observed higher content of DHA in fractions 7-8 is
probably due to their contamination with ROS membranes. Mean
values ± S.E. from n = 8-10 individual
determinations are shown and expressed as nmol of fatty acids/µg of
protein. Inset, mol % content of DHA in subcellular
fractions.
[View Larger Version of this Image (31K GIF file)]
DISCUSSION
This study provides the first available information about the
closely coordinated trafficking, sorting, and association of newly
synthesized [3H]DHA-PLs with [35S]rhodopsin
in frog photoreceptors as the two major membrane components initiate
their journey from the rough ER, where they are synthesized, move
through the Golgi, and leave the TGN on post-Golgi vesicles vectorially
driven to ROS for the assembly of new disc membranes. Our results also
yield several other important findings: (a) free [3H]DHA may be incorporated by turnover in disc PLs
although much less efficiently than when utilized in the inner segment
for [3H]DHA-PLs synthesis; (b) some
[3H]DHA-PLs, mainly [3H]DHA-PI, are
actively synthesized in the inner segment, rapidly transported to ROS,
and incorporated into disc membranes; (c) during the short
period of in vitro labeling (1-3 h), the fast labeling of
all disc membranes by molecular replacement (i.e. protein-mediated transport of [3H]DHA-PLs and/or
[3H]DHA incorporation by turnover) as compared with the
labeling of a few discs at the base by membrane replacement, makes it
difficult to assess the contribution of the latter mechanism to the
overall labeling of ROS lipids.
The time course of [35S]rhodopsin labeling through the
different compartments of the secretory pathway reflects its
vesicle-mediated vectorial traffic from the site of synthesis at the
rough ER to only one destination, ROS. The well defined early
accumulation of [35S]rhodopsin in Golgi fractions by
1 h of labeling followed by its displacement during the subsequent
2-h chase toward TGN and post-Golgi vesicles recovered in fraction 5 (14 and Fig. 1) was used as a marker of membrane flow to follow the
fate of newly synthesized [3H]DHA-lipids. Labeled lipids
recovered in Golgi and TGN-enriched fractions at any time represent
newly synthesized lipids that become constitutive components of the
membranes as well as the different [3H]DHA-lipid pools
that are in transit through these compartments to different
destinations. [3H]DHA-lipids labeling of post-Golgi
vesicles (fraction 5), however, is a clear indication of those newly
synthesized [3H]DHA-lipids cotransported with
[35S]rhodopsin to ROS.
Within the first hour of pulse labeling, [3H]DHA
incorporation into lipids reached similar values in all subcellular
fractions. This rapid equilibrium [3H]DHA-lipids among
all fractions was also reflected in a similar mol % content of
endogenous DHA (20%). Only fractions 7-9, contaminated with ROS
membranes, displayed higher mol % values. Thus, newly synthesized
[3H]DHA-lipids were rapidly transported throughout the
multiple compartments of the biosynthetic pathway either by vesicle
budding and fusion, by carrier proteins, and/or by lateral diffusion
through intermembrane bridges (17, 18). Incorporation of
[3H]DHA by turnover in lipids trafficking along the
transport pathway could also contribute to the uniform labeling
distribution observed among subcellular fractions.
After the 2-h "chase" labeling in cold buffer, it became apparent
that the high labeling of free [3H]DHA in ROS was not
paralleled by an efficient esterification into disc membrane
phospholipids but rather by a translocation to the inner segment where
it was actively esterified. This could be accomplished by the presence
of (a) DHA-fatty acid binding proteins in ROS (45) and in
the cytosolic fraction of retinas (46, 47) and (b) DHA-CoA
synthetase in microsomes. This enzyme that activates DHA prior to its
esterification into lipids displays the highest activity in microsomes
from frog retinas and very low activity in ROS (48). Although free DHA
can be incorporated in disc membrane PLs by turnover of their acyl
groups (49-51), our present results indicate that the bulk of DHA is
incorporated into lipids in the inner segment prior to their delivery
to ROS (52). Indeed, the similar or higher specific activity of total [3H]DHA-lipids observed in the ER-enriched fractions as
compared with other fractions enriched in membranes of the Golgi and
post-Golgi supports this notion.
An interesting observation after the 2-h cold chase incubation was that
the increase in [3H]DHA-lipids labeling was not of the
same magnitude for all subcellular fractions (Figs. 2 and 3). It showed
a clear trend from a 2-fold increase in ER and Golgi, to 2.5-fold in
TGN, and the highest 4-fold increase in post-Golgi vesicles (gradient
fraction 5). Because these fractions also became heavily labeled with
newly synthesized [35S]rhodopsin after the chase, it
appears that some newly synthesized [3H]DHA-PLs are
sorted, along with newly synthesized [35S]rhodopsin in
transit toward the TGN exit. The highest [3H]DHA-PLs
labeling observed in [35S]rhodopsin-bearing post-Golgi
vesicles suggests that they budded from microdomains in the TGN
enriched in both [3H]DHA-PLs and
[35S]rhodopsin. In fact, rhodopsin shows a preference for
association with more fluid lipids (53), and in ROS PLs with high DHA
content are in closer association with rhodopsin than less unsaturated ones (54). That the highest [3H]DHA-PLs labeling in
post-Golgi vesicles observed after the 2-h "chase" could be the
result of differences in lipid turnover in this fraction is unlikely
since (a) labeling gradually increased from Golgi to
post-Golgi vesicles, (b) no differences in the specific activity (total [3H]DHA-PLs/endogenous DHA content)
between post-Golgi vesicles and ER fraction was observed, and
(c) after 1-h pulse labeling post-Golgi vesicles did not
show higher labeling than other fractions. Taken together these data
strongly argue in favor of a progression of label through a series of
compartments. Moreover, the similar [3H]DHA-lipid
labeling observed after 1 h among all subcellular fractions also
suggests an early association between newly synthesized DHA-lipids and
newly synthesized rhodopsin rather than with older rhodopsin molecules
already moving ahead in transit through the Golgi.
The profile of individual [3H]DHA-lipids labeling in
subcellular fractions after the 2-h "chase" was very similar for
the two main membrane components PE and PC, which also displayed the
highest increase of labeling in post-Golgi vesicles (Fig. 3). This
observation and the very low labeling of [3H]DHA-PC and
[3H]DHA-PE recovered in ROS (Figs. 3 and 4) suggests that
their incorporation into disc membranes mainly occurs by membrane
replacement. Our preliminary studies using brefeldin A, which perturbs
rhodopsin trafficking, show that [3H]DHA-PL and
[35S]rhodopsin transfer into fraction 5, PE and PC, in
particular, were successfully blocked, and also that ROS lipid labeling
was reduced.2 At difference with PE and PC,
[3H]DHA-PI displayed a more sustained increase throughout
TGN peaking in post-Golgi fracton 5. Although the labeling of
[3H]DHA-DAG was much lower than that of
[3H]DHA-PI (Fig. 4), both followed a very similar profile
(Fig. 3), probably reflecting an active phosphodiesteratic catabolism of PI with the consequent generation of labeled DAG along the TGN
compartment. In ROS, [3H]DHA-DAG and
[3H]DHA-PI displayed the highest labeling (Fig. 4),
suggestive of their active translocation and incorporation in disc
membranes by molecular replacement. Several lines of experimental
evidence appear to indicate that PI, synthesized de novo in
the inner segment of photoreceptors, can actively be transferred to ROS
by-passing the Golgi (24, 28). In ROS, PI can be further phosphorylated to phosphatidylinositol 4,5-bisphosphate (9, 55). Because ROS contains
a light-stimulated phosphoinositide-specific phospholipase C (56, 57),
the presence of a photoreceptor cytosolic PI-TP, possibly similar to
the one found in rat brain cytosol (58), could contribute to sustain
and modulate the inositol lipid-derived signals triggered by light.
Frog and primate retinas labeled in vitro and/or in
vivo with [3H]DHA display an early high level of
labeling of PI, reaching values similar to that of PC and PE (29, 30,
59). In the present study, we confirm and further extend our previous
observation to show that [3H]DHA-PI preferentially
accumulates in the lightest fractions 1-3 of the gradient where
cytosolic proteins are recovered (12), and also in ROS and in TGN
fractions. The high ratio [3H]DHA-PI to
[3H]DHA-PC found in TGN fractions 7-9 of frog retinas is
the first evidence indicating a relative enrichment with newly
synthesized [3H]DHA-PI of membranes located at the exit
from the TGN compartment. As previously shown in yeast (19) and on PC12
cells (60), the high PI/PC ratio may also be essential for budding of
rhodopsin-bearing vesicles from TGN and further suggests the
involvement of PI/PC-TP in the dynamics of Golgi function in
photoreceptors. Moreover, PI-TP has been identified as a cytosolic
factor that stimulates the formation of secretory vesicles in PC12
cells (60). Since membranes recovered in TGN-enriched fractions 6-11
also contain synaptophysin, a synaptic membrane protein (12), further
studies are necessary to evaluate the possible contribution of
[3H]DHA-PI, in transit together with synaptophysin toward
synaptic terminals, to the high [3H]DHA-PI in TGN
fractions 7-9. The overall contribution of synaptic protein
biosynthesis in this fraction must be relatively minor, however, since
rhodopsin synthesis greatly exceeds the rate of synthesis of all other
retinal membrane proteins (61).
Post-Golgi vesicles recovered from the gradient fraction 5 ( = 1.09 g/ml) display lower density than ROS which sediments in fractions 7-8
( = 1.12-1.13) and therefore must have a higher lipid to
protein ratio (12). This is also supported by freeze-fracture EM
studies (62) showing that vesicles clustered around the connecting cilium display half the density of the intramembranous particle of ROS
disks. Since in post-Golgi vesicles the total acyl group content,
derived mainly from PLs (4.2 nmol/µg protein), was similar to that of
the ROS (3.9 nmol/µg protein), other lipids such as sterols
presumably contribute to their lower density. Cholesterol delivery to
ROS may be accomplished either by a pathway(s) independent from that
followed by integral plasma membrane proteins (18, 63) and/or together
with rhodopsin and DHA-lipid-containing post-Golgi vesicles. As
vesicles fuse with the plasma membrane adjacent to the base of the
connecting cilium, they could generate the cholesterol-enriched domains
observed in frog photoreceptors surrounding the periciliary ridge
complex (64, 65) and in nascent discs at the base of the ROS (66).
In summary, this study shows that newly synthesized
[3H]DHA-PLs, mainly [3H]DHA-PC and
[3H]DHA-PE, are vectorially cotransported to ROS by
rhodopsin-bearing post-Golgi vesicles, and other PLs such as
[3H]DHA-PI may also reach ROS and the TGN by-passing the
Golgi carried by transfer proteins. Moreover, in the complex process of
membrane biogenesis, addition of rhodopsin and DHA-PLs at the base of
ROS could be "the driving force" for the incorporation of other PLs that do not contain DHA (approximately 40-50% of total PLs in disc
membranes) possibly reaching the periciliary region by independent pathways. Current studies aim to delineate the mechanism(s) that contribute to the complex polarized trafficking of DHA-PLs either by
vesicular and/or by transfer protein-mediated transport to ROS.
FOOTNOTES
*
This work was supported by funding from DAMD 17-93-V-3013
(to N. G. B.) and EY 6891 (to D. S. P. and D. D.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: LSU Neuroscience
Center, 2020 Gravier St., Suite B, New Orleans, LA 70112. Tel.: 504-568-6700 (ext. 321); Fax: 504-568-5801; E-mail:
nbazan{at}lsumc.edu.
1
The abbreviations used are: ROS, rod outer
segment(s); PLs, phospholipids; DHA, 22:6n-3, docosahexaenoic acid; PA,
phosphatidic acid; PC, phosphatidylcholine; PE,
phosphatidylethanolamine; PS, phosphatidylserine; PI,
phosphatidylinositol; DAG, diacylglycerol; ER, endoplasmic reticulum;
TGN, trans-Golgi network; TP, transfer proteins.
2
D. Deretic et al., manuscript in
preparation.
ACKNOWLEDGEMENTS
We thank R. E. Anderson for thoughtful
discussions of the results and Nilda Parkins, Belen Puleo-Scheppke, and
Claudia Trippe for their excellent technical assistance.
REFERENCES
-
Papermaster, D. S., and Dreyer, W. J.
(1974)
Biochemistry
13,
2438-2444
[CrossRef][Medline]
[Order article via Infotrieve]
-
Aveldaño de Caldironi, M. I., and Bazan, N. G.
(1980)
Neurochem. Int.
1,
381-392
[CrossRef]
-
Aveldaño, M. I., and Bazan, N. G.
(1983)
J. Lipid Res.
24,
620-627
[Abstract]
-
Fliesler, S. J., and Anderson, R. E.
(1983)
Prog. Lipid Res.
22,
79-131
[CrossRef][Medline]
[Order article via Infotrieve]
-
Wiegand, R. D., and Anderson, R. E.
(1983)
Exp. Eye Res.
37,
150-173
-
Choe, H.-G., and Anderson, R. E.
(1990)
Exp. Eye Res.
51,
159-165
[CrossRef][Medline]
[Order article via Infotrieve]
-
Besharse, J. C.
(1986)
in
The Retina: A Model for Cell Biological Studies (Adler, R., and Farber, D., eds), pp. 297-352, Academic Press, Inc., New York
-
Deretic, D., and Papermaster, D. S.
(1995)
in
Progress in Retinal and Eye Research (Osborne, N. N., and Chadek, G. J., eds), Vol. 14, pp. 249-265, Pergamon Press Inc., Tarrytown, NY
[CrossRef]
-
Choe, H.-G., Ghalayini, A. J., and Anderson, R. E.
(1990)
Exp. Eye Res.
51,
167-176
[CrossRef][Medline]
[Order article via Infotrieve]
-
Mercurio, A. M., and Holtzman, E.
(1982)
J. Neurocytol.
11,
295-322
[CrossRef][Medline]
[Order article via Infotrieve]
-
Papermaster, D. S., Schneider, B. G., Defoe, D., and Besharse, J. C.
(1986)
J. Histochem. Cytochem.
34,
5-16
[Abstract]
-
Deretic, D., and Papermaster, D. S.
(1991)
J. Cell Biol.
113,
1281-1293
[Abstract/Free Full Text]
-
Deretic, D., and Papermaster, D. S.
(1993)
J. Cell Sci.
106,
803-813
[Abstract]
-
Deretic, D., Aebersold, R. H., Morrison, H. D., and Papermaster, D. S.
(1994)
J. Biol. Chem.
269,
16853-16861
[Abstract/Free Full Text]
-
Deretic, D., Huber, L. A., Ransom, N., Mancini, M., Simons, K., and Papermaster, D. S.
(1995)
J. Cell Sci.
108,
215-224
[Abstract]
-
Bishop, W. R., and Bell, R. M.
(1988)
Annu. Rev. Cell Biol.
4,
579-610
[CrossRef]
-
Pagano, R. E.
(1990)
Curr. Opin. Cell Biol.
2,
652-663
[CrossRef][Medline]
[Order article via Infotrieve]
-
Voelker, D. R.
(1991)
Microbiol. Rev.
55,
543-560
[Abstract/Free Full Text]
-
Cleves, A., McGee, T., and Bankaitis, V.
(1991)
Trends Cell Biol.
1,
30-34
[CrossRef][Medline]
[Order article via Infotrieve]
-
Dudley, P. A., and Anderson, R. E.
(1978)
FEBS Lett.
95,
57-60
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sellner, P. A., Dalton, T. P., and Helmkamp, G. M. (1991) Invest.
Ophthalmol. & Visual Sci. 32, Suppl. ARVO, 1149
-
Bibb, C., and Young, R. W.
(1974)
J. Cell Biol.
61,
327-343
[Abstract/Free Full Text]
-
Young, R. W.
(1976)
Invest. Ophthalmol.
15,
700-725
-
Fliesler, S. J., and Basinger, S. F.
(1987)
J. Biol. Chem.
262,
17516-17523
[Abstract/Free Full Text]
-
Fliesler, S. J., Florman, R., and Keller, R. K.
(1995)
Exp. Eye Res.
60,
57-69
[CrossRef][Medline]
[Order article via Infotrieve]
-
Matheke, M. L., Fliesler, S. J., Basinger, S. F., and Holtzman, E.
(1984)
J. Neurosci.
4,
1086-1093
[Abstract]
-
Matheke, M. L., and Holtzman, E.
(1984)
J. Neurosci.
4,
1093-1103
[Abstract]
-
Wetzel, M. G., Bendala-Tufanisco, E., and Besharse, J. C.
(1993)
J. Neurocytol.
22,
397-412
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rodriguez de Turco, E. B., Gordon, W. C., and Bazan, N. G.
(1991)
J. Neurosci.
11,
3667-3678
[Abstract]
-
Rodriguez de Turco, E. B., Gordon, W. C., and Bazan, N. G.
(1993)
Curr. Eye Res.
13,
21-28
-
Gordon, W. C., and Bazan, N. G.
(1990)
J. Neurosci.
10,
2190-2202
[Abstract]
-
Gordon, W. C., and Bazan, N. G.
(1993)
Invest. Ophthalmol. & Visual Sci.
34,
2402-2411
[Abstract/Free Full Text]
-
Deretic, D., and Papermaster, D. S.
(1993)
in
Methods for the Study of Photoreceptor Cells (Hargrave, P., ed), Vol. 15, pp. 108-120, Rockefeller University Press, New York
-
Louie, K., Wiegand, R. D., and Anderson, R. E.
(1988)
Biochemistry
27,
9014-9020
[CrossRef][Medline]
[Order article via Infotrieve]
-
Bazan, N. G.
(1982)
in
Phospholipids in the Nervous System (Horrocks, L. A., Ansell, G. B., and Porcellati, G., eds), pp. 49-62, Raven Press, NY
-
Bazan, N. G., Reddy, T. S., Bazan, H. E. P., and Birkle, D. L.
(1986)
Prog. Lipid Res.
25,
595-606
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rotstein, N. P., and Aveldaño, M. I.
(1987)
Biochim. Biophys. Acta
921,
221-234
[Medline]
[Order article via Infotrieve]
-
Rotstein, N. P., and Aveldaño, M. I.
(1987)
Biochim. Biophys. Acta
921,
235-244
[Medline]
[Order article via Infotrieve]
-
Rodriguez de Turco, E. B., Gordon, W. C., and Bazan, N. G. (1992)
Invest. Ophthalmol. & Visual Sci. 32, Suppl. ARVO,
702
-
Fanger, B. O.
(1987)
Anal. Biochem.
162,
11-17
[CrossRef][Medline]
[Order article via Infotrieve]
-
Folch, J., Lees, M., and Stanley, G. H. S.
(1957)
J. Biol. Chem.
226,
497-509
[Free Full Text]
-
Marcheselli, V. L., and Bazan, N. G.
(1990)
J. Nutr. Biochem.
1,
231-237
-
Deretic, D., Puleo-Scheppke, B., and Trippe, C.
(1996)
J. Biol. Chem.
271,
2279-2286
[Abstract/Free Full Text]
-
Roque, M. E., and Giusto, N. M.
(1995)
Exp. Eye Res.
60,
631-643
[CrossRef][Medline]
[Order article via Infotrieve]
-
Jiao, X., Gentleman, S., Wetzel, M. G., O'Brien, P., and Chader, G. F. (1993) Invest. Ophthalmol. & Visual Sci. 34, (suppl.)
1328
-
Sellner, P.
(1994)
Invest. Ophthalmol. & Visual Sci.
35,
443-452
[Abstract/Free Full Text]
-
Lee, J., Jiao, X., Gentleman, S., Wetzel, M. G., O'Brien, P., and Chader, G. F.
(1995)
Invest. Ophthalmol. & Visual Sci.
36,
2032-2039
[Abstract/Free Full Text]
-
Reddy, T. S., and Bazan, N. G.
(1984)
Curr. Eye Res.
3,
1225-1232
[Medline]
[Order article via Infotrieve]
-
Giusto, N. M., Boschero, M. I., Sprecher, H., and Aveldaño, M. I.
(1986)
Biochim. Biophys. Acta
860,
137-148
[Medline]
[Order article via Infotrieve]
-
Zimmerman, W. F., and Keys, S.
(1988)
Exp. Eye Res.
47,
247-260
[CrossRef][Medline]
[Order article via Infotrieve]
-
Louie, K., Zimmerman, W. F., Keys, S., and Anderson, R. E.
(1991)
Exp. Eye Res.
53,
309-316
[CrossRef][Medline]
[Order article via Infotrieve]
-
Bazan, N. G.
(1990)
Nutrition and the Brain, pp. 1-24, Raven Press, Ltd, New York
-
Chen, Y. S., and Hubbel, W. L.
(1973)
Exp. Eye Res.
17,
517-532
[CrossRef][Medline]
[Order article via Infotrieve]
-
Aveldaño, M. I.
(1988)
Biochemistry
27,
1229-1239
[CrossRef][Medline]
[Order article via Infotrieve]
-
Giusto, N. M., and Ilincheta de Boschero, M. G.
(1986)
Biochim. Biophys. Acta
877,
440-446
[Medline]
[Order article via Infotrieve]
-
Ghalayini, A. J., and Anderson, R. E.
(1984)
Biochem. Biophys. Res. Commun.
124,
503-506
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ghalayini, A. J., and Anderson, R. E.
(1992)
J. Biol. Chem.
267,
17977-17982
[Abstract/Free Full Text]
-
Thomas, G. M. H., Cunningham, E., Fensome, A., Ball, A., Totty, N. F., Troung, O., et al.
(1993)
Cell
74,
919-928
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rodriguez de Turco, E. B., Gordon, W. C., Peyman, G. A., and Bazan, N. G.
(1990)
J. Neurosci. Res.
27,
522-532
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ohashi, M., de Vries, K. J., Frank, R., Snoek, G., Bankaitis, V., Wirtz, K., and Hutter, W. B.
(1995)
Nature
377,
544-547
[CrossRef][Medline]
[Order article via Infotrieve]
-
Papermaster, D. S., Converse, C. A., and Siu, J.
(1975)
Biochemistry
14,
1343-1352
[CrossRef][Medline]
[Order article via Infotrieve]
-
Besharse, J. C., and Pfenninger, K. H.
(1980)
J. Cell Biol.
87,
451-463
[Abstract/Free Full Text]
-
Urbani, L., and Simoni, R. D.
(1990)
J. Biol. Chem.
265,
1919-1923
[Abstract/Free Full Text]
-
Andrews, L. D., and Cohen, A. I.
(1981)
Exp. Eye Res.
33,
1-10
[CrossRef][Medline]
[Order article via Infotrieve]
-
Andrews, L. D., and Cohen, A. I.
(1983)
J. Cell Biol.
97,
749-755
[Abstract/Free Full Text]
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Mazelova, N. Ransom, L. Astuto-Gribble, M. C. Wilson, and D. Deretic
Syntaxin 3 and SNAP-25 pairing, regulated by omega-3 docosahexaenoic acid, controls the delivery of rhodopsin for the biogenesis of cilia-derived sensory organelles, the rod outer segments
J. Cell Sci.,
June 15, 2009;
122(12):
2003 - 2013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Abe, Y. Hayashi, Y. Hama, M. Hayashi, M. Inagaki, and M. Ito
A Novel Phosphatidylcholine Which Contains Pentadecanoic Acid at sn-1 and Docosahexaenoic Acid at sn-2 in Schizochytrium sp. F26-b
J. Biochem.,
August 1, 2006;
140(2):
247 - 253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Garelli, N. P. Rotstein, and L. E. Politi
Docosahexaenoic Acid Promotes Photoreceptor Differentiation without Altering Crx Expression.
Invest. Ophthalmol. Vis. Sci.,
July 1, 2006;
47(7):
3017 - 3027.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Park, M. Suh, and M. T. Clandinin
Dietary Ganglioside and Long-Chain Polyunsaturated Fatty Acids Increase Ganglioside GD3 Content and Alter the Phospholipid Profile in Neonatal Rat Retina
Invest. Ophthalmol. Vis. Sci.,
July 1, 2005;
46(7):
2571 - 2575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Deretic, V. Traverso, N. Parkins, F. Jackson, E. B. R. de Turco, and N. Ransom
Phosphoinositides, Ezrin/Moesin, and rac1 Regulate Fusion of Rhodopsin Transport Carriers in Retinal Photoreceptors
Mol. Biol. Cell,
January 1, 2004;
15(1):
359 - 370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Seddon, B. Rosner, R. D. Sperduto, L. Yannuzzi, J. A. Haller, N. P. Blair, and W. Willett
Dietary Fat and Risk for Advanced Age-Related Macular Degeneration
Arch Ophthalmol,
August 1, 2001;
119(8):
1191 - 1199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Rodriguez de Turco, W. Tang, M. K. Topham, F. Sakane, V. L. Marcheselli, C. Chen, A. Taketomi, S. M. Prescott, and N. G. Bazan
Diacylglycerol kinase varepsilon regulates seizure susceptibility and long-term potentiation through arachidonoyl- inositol lipid signaling
PNAS,
March 29, 2001;
(2001)
81536298.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Marx, R. El Meskini, D. C. Johns, and R. E. Mains
Differences in the Ways Sympathetic Neurons and Endocrine Cells Process, Store, and Secrete Exogenous Neuropeptides and Peptide-Processing Enzymes
J. Neurosci.,
October 1, 1999;
19(19):
8300 - 8311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Krappa, A. Nguyen, P. Burrola, D. Deretic, and G. Lemke
Evectins: Vesicular proteins that carry a pleckstrin homology domain and localize to post-Golgi membranes
PNAS,
April 13, 1999;
96(8):
4633 - 4638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Deretic, S. Schmerl, P. A. Hargrave, A. Arendt, and J. H. McDowell
Regulation of sorting and post-Golgi trafficking of rhodopsin by its C-terminal sequence QVS(A)PA
PNAS,
September 1, 1998;
95(18):
10620 - 10625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Rodriguez de Turco, W. Tang, M. K. Topham, F. Sakane, V. L. Marcheselli, C. Chen, A. Taketomi, S. M. Prescott, and N. G. Bazan
Diacylglycerol kinase varepsilon regulates seizure susceptibility and long-term potentiation through arachidonoyl- inositol lipid signaling
PNAS,
April 10, 2001;
98(8):
4740 - 4745.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|